scispace - formally typeset
K

Keerti V. Shah

Researcher at Johns Hopkins University

Publications -  364
Citations -  50317

Keerti V. Shah is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Cervical cancer & Virus. The author has an hindex of 87, co-authored 363 publications receiving 48386 citations. Previous affiliations of Keerti V. Shah include University of California, Los Angeles & McGill University.

Papers
More filters
Journal ArticleDOI

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

TL;DR: The presence of HPV in virtually all cervical cancers implies the highest worldwide attributable fraction so far reported for a specific cause of any major human cancer, and the rationale for HPV testing in addition to, or even instead of, cervical cytology in routine cervical screening.
Journal ArticleDOI

Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

TL;DR: In addition to HPV types 16 and 18, types 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73, and 82Should be considered carcinogenic, or high-risk, types, and types 26, 53, and 66 should be considered probably carcinogenic.
Journal ArticleDOI

The causal relation between human papillomavirus and cervical cancer

TL;DR: It is the right time for medical societies and public health regulators to consider the causal role of human papillomavirus infections in cervical cancer and to define its preventive and clinical implications.
Journal ArticleDOI

Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective

TL;DR: The results confirm the role of genitalHPVs, which are transmitted sexually, as the central etiologic factor in cervical cancer worldwide and suggest that most genital HPVs are associated with cancer, at least occasionally.
Journal ArticleDOI

Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers

TL;DR: It is suggested that HPV-positive oropharyngeal cancers comprise a distinct molecular, clinical, and pathologic disease entity that is likely causally associated with HPV infection and that has a markedly improved prognosis.